A positive correlation between MAPT mRNA levels and survival was also reported in other cancers such as low-grade glioma, breast cancer, kidney clear cell carcinoma, lung adenocarcinoma, and pheochromocytoma/paraganglioma [27, 43]. The gene discussed is MAPT; the disease is paraganglioma.